Table 2. Distribution of characteristics of the type and cancer stage according treatment groups.
| TENS Placebo (n=13) | TENS Ativo (n=11) | Total (n=24) | ||||
|---|---|---|---|---|---|---|
| N | % | N | % | N | % | |
| Type of tumor | ||||||
| Breast | 9 | 69.2 | 4 | 36.4 | 13 | 54.2 |
| Colorectal | 4 | 30.8 | 7 | 63.6 | 11 | 45.8 |
| T | ||||||
| T1 | 0 | 0.0 | 1 | 9.1 | 1 | 4.2 |
| T2 | 6 | 46.2 | 2 | 18.2 | 8 | 33.3 |
| T3 | 6 | 46.2 | 7 | 63.6 | 13 | 54.2 |
| T4 | 1 | 7.6 | 1 | 9.1 | 2 | 8.3 |
| N | ||||||
| N0 | 4 | 30.8 | 5 | 45.5 | 9 | 37.5 |
| N1 | 6 | 46.2 | 5 | 45.5 | 11 | 45.8 |
| N2 | 3 | 23.0 | 1 | 9.0 | 4 | 16.7 |
| N3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| M | ||||||
| M0 | 6 | 46.2 | 9 | 81.8 | 15 | 62.5 |
| M1 | 5 | 38.5 | 2 | 18.2 | 7 | 29.2 |
| M3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Mx | 2 | 15.3 | 0 | 0.0 | 2 | 8.3 |
χ2 test Pearson, *p>0.01